» Articles » PMID: 17785446

The DNA Binding and Catalytic Domains of Poly(ADP-ribose) Polymerase 1 Cooperate in the Regulation of Chromatin Structure and Transcription

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2007 Sep 6
PMID 17785446
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

We explored the mechanisms of chromatin compaction and transcriptional regulation by poly(ADP-ribose) polymerase 1 (PARP-1), a nucleosome-binding protein with an NAD(+)-dependent enzymatic activity. By using atomic force microscopy and a complementary set of biochemical assays with reconstituted chromatin, we showed that PARP-1 promotes the localized compaction of chromatin into supranucleosomal structures in a manner independent of the amino-terminal tails of core histones. In addition, we defined the domains of PARP-1 required for nucleosome binding, chromatin compaction, and transcriptional repression. Our results indicate that the DNA binding domain (DBD) of PARP-1 is necessary and sufficient for binding to nucleosomes, yet the DBD alone is unable to promote chromatin compaction and only partially represses RNA polymerase II-dependent transcription in an in vitro assay with chromatin templates (approximately 50% of the repression observed with wild-type PARP-1). Furthermore, our results show that the catalytic domain of PARP-1, which does not bind nucleosomes on its own, cooperates with the DBD to promote chromatin compaction and efficient transcriptional repression in a manner independent of its enzymatic activity. Collectively, our results have revealed a novel function for the catalytic domain in chromatin compaction. In addition, they show that the DBD and catalytic domain cooperate to regulate chromatin structure and chromatin-dependent transcription, providing mechanistic insights into how these domains contribute to the chromatin-dependent functions of PARP-1.

Citing Articles

Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia.

Bian X, Liu W, Yang K, Sun C Front Pharmacol. 2024; 15:1421816.

PMID: 39175540 PMC: 11338796. DOI: 10.3389/fphar.2024.1421816.


PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics.

Sobotka A, Tempera I Pathogens. 2024; 13(2).

PMID: 38392869 PMC: 10891851. DOI: 10.3390/pathogens13020131.


ADP-ribosylation from molecular mechanisms to therapeutic implications.

Suskiewicz M, Prokhorova E, Rack J, Ahel I Cell. 2023; 186(21):4475-4495.

PMID: 37832523 PMC: 10789625. DOI: 10.1016/j.cell.2023.08.030.


PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA mA methylation to control cancer cell radiosensitivity.

Sun X, Bai C, Li H, Xie D, Chen S, Han Y Mol Ther. 2023; 31(9):2633-2650.

PMID: 37482682 PMC: 10492194. DOI: 10.1016/j.ymthe.2023.07.018.


Cooperative targeting of PARP-1 domains to regulate metabolic and developmental genes.

Bamgbose G, Johnson S, Tulin A Front Endocrinol (Lausanne). 2023; 14:1152570.

PMID: 37347109 PMC: 10281051. DOI: 10.3389/fendo.2023.1152570.


References
1.
Bustamante C, Zuccheri G, Leuba S, Yang G, Samori B . Visualization and analysis of chromatin by scanning force microscopy. Methods. 1997; 12(1):73-83. DOI: 10.1006/meth.1997.0449. View

2.
Robinson P, Rhodes D . Structure of the '30 nm' chromatin fibre: a key role for the linker histone. Curr Opin Struct Biol. 2006; 16(3):336-43. DOI: 10.1016/j.sbi.2006.05.007. View

3.
Georgel P, Hansen J . Linker histone function in chromatin: dual mechanisms of action. Biochem Cell Biol. 2001; 79(3):313-6. View

4.
Narlikar G, Fan H, Kingston R . Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002; 108(4):475-87. DOI: 10.1016/s0092-8674(02)00654-2. View

5.
Cheung E, Zarifyan A, Kraus W . Histone H1 represses estrogen receptor alpha transcriptional activity by selectively inhibiting receptor-mediated transcription initiation. Mol Cell Biol. 2002; 22(8):2463-71. PMC: 133703. DOI: 10.1128/MCB.22.8.2463-2471.2002. View